Intrauterine Insemination (IUI) Devices Market by Product Type (IUI Catheters, IUI Media/Sperm Wash), End user (Hospitals, IVF Clinics) & Region - Forecast to 2020-2030

Introduction

The global intrauterine insemination (IUI) devices market is witnessing lucrative opportunities with significant improvements to success rates in assisted reproduction practices. A new study recently published by Future Market Insights has indicated that the market is expected to cross US$ 36 million by 2020. The market is also estimated to reflect a steady CAGR of 3.8% through 2030.

Legal and Ethical Consideration Remain Important

In recent years, intrauterine insemination devices have become increasingly popular for people struggling to conceive. However, ethical and legal consideration remain a concern for market players.

According to the guidelines by the Indian Council of Medical Research, trauma and metal issues from infertility are key factors that should be considered while promoting solutions including intrauterine insemination devices.

Emerging economies in East and South Asia have witnessed a surge in IVF clinics, many of which do not adhere strictly to government supervisions and regulations, potentially creating risks for patients and for the children conceived. Consequently, lobbying for strict protections for patients and awareness campaigns to reduce social stigma will remain important to market players.

Use of Intrauterine Insemination in Same Sex Couples

For same sex couples seeking to conceive, intrauterine insemination devices have become a highly popular option. While social stigma and archaic laws remain an issue in many countries, changes in legislation have opened up opportunities for such parents, and also for players in the IUI devices market.

IUI devices are more popular among same sex couples, in comparison to conventional IVF treatments owing to ease of use, lower costs, and non-invasive nature.

Also, advances in AI and automation, which enables higher success rates through monitoring hormonal levels and other health parameters will also drive adoption for the foreseeable future.

Products for Home Care Settings Gain Traction

According to the American Pregnancy Association, the use of intrauterine insemination devices has gained popularity among people suffering from hostile cervical conditions, cervical mucus issues, scar tissues, and ejaculation dysfunction in males.

With advances in fertility treatments, including ovulation stimulation medications, home setting treatments have been gradually finding buyers, with portable IUI devices becoming increasingly mainstream.

OTC offerings from the intrauterine insemination devices market are likely to gain ground over the forecast period. The Stork Home Conception Aid is one such product which has its presence in key markets around the world.

Key Challenges

Intrauterine insemination devices are increasingly sought after in the commercial fertility services sector. However, the market is likely to be hindered during the forecast period owing to a number of challenges. A key factor holding back the market is the high costs of fertility treatments, provided at IVF clinics and hospitals.

Also, developing countries face the challenge of lack of insurance coverage for fertility treatments, which also limits the adoption of intrauterine insemination devices, owing to prohibitive out of pocket expenditure. Social stigma associated to infertility remains a major issue. Regulations hindering same sex couples is also an obstacle for the industry.

Region-wise Insights

East Asia Intrauterine Insemination (IUI) Devices Market

East Asia, led by China is a key market for intrauterine insemination devices. The region has a massive population pool, and the costs of artificial insemination is relatively lower in the region. The market is estimated to account for around 40% of the global market share.

The prominent position of East Asia in the intrauterine insemination market can be largely be attributed to the growing numbers of regional players and supportive government policies to fertility treatment. In addition, medical tourism for fertility treatments is also on the rise. However, lower diagnostic rates in rural areas limit the presence of the industry.

China, in particular, has faced a challenge in terms of declining working populations, and has scrapped its one-child policy around 10% of the population faces fertility issues, in addition to complications during child birth procedures. These factors are likely to contribute to the long term development of the market here.

Request a sample specific to East Asia market

South Asia Intrauterine Insemination (IUI) Devices Market

The South Asian market for intrauterine insemination devices is second only to East Asia, and is the fastest growing regional market in the world. Led by India, the region is reflecting a growing number of infertility cases, which has bolstered demand for intrauterine insemination devices to meet the needs of a wide consumer base.

Also, the growing number of IVF clinics around the region and investments from the public and private sectors towards the modernization of healthcare infrastructure is expected to support market growth in the long term.

However, restrictions on logistics, and the lack of awareness about intrauterine insemination devices particularly in rural areas is expected hinder the potential for growth in the industry, which in turn is pushing market players to develop awareness campaigns for the same.

Request a sample specific to South Asia & Pacific market

North America Intrauterine Insemination (IUI) Devices Market

Apart from the markets in Asia, North America’s market for intrauterine insemination devices, is expected to reflect a positive trajectory for the forecast years. North America is a major market for artificial insemination solutions. Favorable rules and regulations and easier access to cutting edge technologies will support the prospects of the market.

North America led by the United States accounts for more than 15% of the global market share. Many states in the region have set up legislations enabling insurance for fertility treatments. This in turn is a key driver for demand affecting the pricing and revenue in the intrauterine insemination devices market. Manufacturers in the region are also leveraging awareness campaigns, and the rise in disposable incomes to bolster sales. These trends are likely to boost market growth here for the foreseeable future. 

Category-Wise Insights

Sperm Wash Devices to Hold Lead

Intrauterine insemination (IUI) devices can largely be classified into IUI catheters and IUI media/sperm wash devices. IUI catheter devices can be further segmented into curved, flexible and straight variants. IUI media/sperm wash devices are expected to hold major market share of over 60% through the end of the assessment period.

The demand for intrauterine insemination mediums/sperm wash devices are expected to be driven by improvements in aseptic sanitization, ease of use, longer shelf life, lack of need for carbon dioxide incubation, and heparin-free operations. These factors will enable long-term growth prospects in the industry.

IVF Clinics Remain Primary Users

Intrauterine insemination devices are primarily used by hospitals and IVF clinics. Of these, the use of intrauterine insemination devices will remain higher among IVF clinics, which will account for more than 55% of the overall revenue share through the end of the forecast period.

Increasing adoption rates of treatment and rapid increase of infertility clinics around the world are key factors driving growth. Expertise in consultations and assistive reproductive procedures will contribute to a relatively higher growth rate for the long-term.

Intrauterine Insemination (IUI) Devices Manufacturers and Competitive Landscape

Leading market players in the fairly fragmented intrauterine insemination devices market have been increasingly focusing on investing into product development and launch strategies. Market players are also pushing for strategic collaborations and acquisitions to improve on geographic and capacity expansions.

For instance, in November 2020, Subhag HealthTech launched V Conceive, the first home-based IUI kit, which the company claims will allow infertile couples to conceive without the need to visit IVF clinics or hospitals.

Reproductive Sciences has unveiled positive results from clinical trials of Evie, a IUI catheter gun, with substantial improvement in success rates in comparison to conventional intrauterine insemination practices. The device requires minimal medical intervention.

Rinovum Women’s Health has launched the Stork Conception Aid for home-based fertility treatment for users in Australia, following launches in the United States, Canada and UK. The device has been added to the Australian Register of Therapeutic Goods.

DxNow Inc. has announced the FDA approval for its ZyM?t™ ICSI and ZyM?t™ Multi Sperm Separation Devices, for applications in assisted reproductive technology procedures in OB/GYN facilities and fertility clinics.

These developments are likely to generate major lucrative opportunities for intrauterine insemination device suppliers and manufacturers for the foreseeable future.

Aside from these market participants, other leading players in the market include:

• CooperCompany Inc.
• Cook Medical
• Kitazato Corp
• Rocket Medical Plc
• Prince Medical
• Gynotec B.V.
• Surgimedik Healthcare
• Medgyn
• MedTech Devices Pvt. Ltd.

The list is only indicative – full list of intrauterine insemination (IUI) devices market key players is available upon request.

Intrauterine Insemination (IUI) Devices Market Report: Scope

Enquiry before Buying

• Is this research conducted by Future Market Insights?

  Yes, the research has been conducted by expert analysts of Future Market Insights through a combination of primary research and secondary research. To know more about how the research was conducted, you can speak to research analyst.

• What research methodology is followed by FMI?

  FMI follows a methodology that encompasses demand side assessment of the market, and triangulates the same through supply side analysis. This methodology is based on use of standard market structure, methods and definitions.

• Who are the respondents for primary research?

  FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. For a full list of primary respondents, please reach out to us.

• What are the sources of secondary research?

  FMI conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request. 

• Is a sample of this report available for evaluation?

  Yes, you can request a sample and it will be sent to you through an email.

• How can I buy this report?

  FMI provides a secure online payment system to buy report seamlessly. You can buy the report securely and safely.

Key Segments

Product Type

• IUI Catheters
  • Curved
  • Flexible
  • Straight
• IUI Media/Sperm Wash

End user

• Hospitals
• IVF Clinics

Region

• North America (U.S., Canada)
• Latin America (Brazil, Mexico, Argentina, and Rest of Latin America)
• Europe (Germany, Italy, France, UK, Spain, Benelux, Russia, Rest of Europe)
• East Asia (China, Japan, South Korea)
• South Asia (India, Thailand, Indonesia, Malaysia, Rest of South Asia)
• Oceania (Australia and New Zealand)
• Middle East & Africa (Saudi Arabia, Turkey, South Africa, Rest of MEA)